The company initiated the recall after concerns with quality control processes were observed during an FDA inspection. The recall specifically includes around 95 dosage units of sterile compound products that were sold to offices in Indiana.
Additional states impacted by the recall include Ohio, Florida, Tennessee and Illinois. Nora has not received reports of injury or illness associated with the use of recalled products.
More Articles on Surgery Centers:
55 Statistics on Risks to Surgery Center Valuation
Big Opportunities for ASCs in Medical Tourism: Q&A With David Miller of Nueterra
6 Hiring Practices for Successful ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
